Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors - Generation of receptor-selective VEGF variants by site-directed mutagenesis

被引:401
作者
Keyt, BA [1 ]
Nguyen, HV [1 ]
Berleau, LT [1 ]
Duarte, CM [1 ]
Park, J [1 ]
Chen, H [1 ]
Ferrara, N [1 ]
机构
[1] GENENTECH INC, DEPT BIOORGAN CHEM, S SAN FRANCISCO, CA 94080 USA
关键词
D O I
10.1074/jbc.271.10.5638
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factor (VEGF) expression in Various cell types is induced by hypoxia and other stimuli. VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)/fetal liver kinase 1 (Flk-1) and FLT-1. Alanine-scanning mutagenesis was used to identify a positively charged surface in VEGF that mediates binding to KDR/Flk-1. Arg(82), Lys(84) and His(86), located in a hairpin loop, were found to be critical for binding KDR/Flk-1, while negatively charged residues, Asp(63), Glu(64), and Glu(67), were associated with FLT-1 binding. A VEGF model based on PDGFb indicated these positively and negatively charged regions are distal in the monomer but are spatially close in the dimer. Mutations within the KDR site had minimal effect on FLT-1 binding, and mutants deficient in FLT-1 binding did not affect KDR binding. Endothelial cell mitogenesis was abolished in mutants lacking KDR affinity; however, FLT-1 deficient mutants induced normal proliferation. These results suggest dual sets of determinants in the VEGF dimer that cross-link cell surface receptors, triggering endothelial cell growth and angiogenesis. Furthermore, this mutational analysis implicates KDR, but not FLT-1, in VEGF induction of endothelial cell proliferation.
引用
收藏
页码:5638 / 5646
页数:9
相关论文
共 60 条
  • [1] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS
    AIELLO, LP
    AVERY, RL
    ARRIGG, PG
    KEYT, BA
    JAMPEL, HD
    SHAH, ST
    PASQUALE, LR
    THIEME, H
    IWAMOTO, MA
    PARK, JE
    NGUYEN, HV
    AIELLO, LM
    FERRARA, N
    KING, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487
  • [2] BINDING AND ENDOCYTOSIS OF HEPARIN BY HUMAN-ENDOTHELIAL CELLS IN CULTURE
    BARZU, T
    MOLHO, P
    TOBELEM, G
    PETITOU, M
    CAEN, J
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 845 (02) : 196 - 203
  • [3] BREIER G, 1992, DEVELOPMENT, V114, P521
  • [4] VASCULAR-PERMEABILITY FACTOR MESSENGER-RNA AND PROTEIN EXPRESSION IN HUMAN KIDNEY
    BROWN, LF
    BERSE, B
    TOGNAZZI, K
    MANSEAU, EJ
    VANDEWATER, L
    SENGER, DR
    DVORAK, HF
    ROSEN, S
    [J]. KIDNEY INTERNATIONAL, 1992, 42 (06) : 1457 - 1461
  • [5] HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA
    CHEN, C
    OKAYAMA, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) : 2745 - 2752
  • [6] VASCULAR-PERMEABILITY FACTOR - A UNIQUE REGULATOR OF BLOOD-VESSEL FUNCTION
    CONNOLLY, DT
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1991, 47 (03) : 219 - 223
  • [7] CONNOLLY DT, 1989, J BIOL CHEM, V264, P20017
  • [8] THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR
    DEVRIES, C
    ESCOBEDO, JA
    UENO, H
    HOUCK, K
    FERRARA, N
    WILLIAMS, LT
    [J]. SCIENCE, 1992, 255 (5047) : 989 - 991
  • [9] PURIFICATION AND CHARACTERIZATION OF A NATURALLY-OCCURRING VASCULAR ENDOTHELIAL GROWTH-FACTOR PLACENTA GROWTH-FACTOR HETERODIMER
    DISALVO, J
    BAYNE, ML
    CONN, G
    KWOK, PW
    TRIVEDI, PG
    SODERMAN, DD
    PALISI, TM
    SULLIVAN, KA
    THOMAS, KA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) : 7717 - 7723
  • [10] Ligand-Induced Homo-and Hetero-Dimerization of Platelet-Derived Growth Factor alpha- and beta-Receptors in Intact Cells
    Eriksson, Anders
    Rorsman, Charlotte
    Ernlund, Agneta
    Claesson-Welsh, Lena
    Heldin, Carl-Henrik
    [J]. GROWTH FACTORS, 1992, 6 (01) : 1 - 14